LEGN · ISSUER CIK 1801198
Legend Biotech Corp
Between Aug 1, 2026 and Oct 29, 2026, 9 Legend Biotech Corp insiders reported $0.00 of open-market purchases and $309K of sales on SEC Form 4.
↗9 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$309KInsider selling
−$309KNet open-market
Oct 1, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 202616:04 | Sep 29, 2026 | LEGN | Director | S · Sell | $9.46 | −27,370 | 52,731 | -34% | −$259K | ||
| Sep 28, 202616:10 | Sep 24, 2026 | LEGN | Director | A · Grant | — | +28,330 | 55,096 | +106% | — | ||
| Sep 28, 202616:10 | Sep 24, 2026 | LEGN | Director | A · Grant | — | +20,986 | 53,720 | +64% | — | ||
| Sep 28, 202616:10 | Sep 24, 2026 | LEGN | Director | A · Grant | — | +20,986 | 65,316 | +47% | — | ||
| Sep 28, 202616:10 | Sep 24, 2026 | LEGN | Director | A · Grant | — | +20,986 | 69,590 | +43% | — | ||
| Sep 28, 202616:10 | Sep 24, 2026 | LEGN | Director | A · Grant | — | +28,330 | 92,103 | +44% | — | ||
| Sep 28, 202616:10 | Sep 24, 2026 | LEGN | Director | A · Grant | — | +20,986 | 80,101 | +36% | — | ||
| Sep 23, 202616:15 | Sep 21, 2026 | LEGN | Chief Financial Officer | S · Sell | $9.14 | −5,430 | 14,246 | -28% | −$50K | ||
| Sep 23, 202616:15 | Sep 21, 2026 | LEGN | Chief Financial Officer | A · Grant | — | +19,676 | 19,676 | New | — | ||
| Sep 16, 202616:18 | Sep 15, 2026 | LEGN | Chief Executive Officer | A · Grant | — | +1,131,860 | 1,131,860 | New | — | ||
| Aug 18, 202616:15 | Aug 14, 2026 | LEGN | Interim CEO | A · Grant | — | +4,908 | 35,142 | +16% | — |